Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 7, 2014; 20(33): 11753-11761
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11753
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11753
Figure 7 Polymerase chain reaction expressions of SREBP1c, FAS, SCD-1, PPAR-α and CROT.
Compared with the NAFLD group, osthol treatment decreased SREBP1c, FAS, and SCD-1 expression (A-C), and increased PPAR-α and CROT expression (D and E). aP < 0.05.
-
Citation: Nam HH, Jun DW, Jeon HJ, Lee JS, Saeed WK, Kim EK. Osthol attenuates hepatic steatosis
via decreased triglyceride synthesis not by insulin resistance. World J Gastroenterol 2014; 20(33): 11753-11761 - URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11753.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11753